Meet us at upcoming conferences!
Munich, Germany, 14-17 May 2025
ESMO Breast Cancer
Biovica will be represented.
Chicago, Illinois, USA, May 30 - Jun 03, 2025
ASCO Annual Meeting
Biovica will be represented.
San Antonio, US, 10-13 December, 2024
SABCS25
Last year Biovica had 7 posters on SABCS24, you can read the booklet here:
“SABCS24 ABSTRACTS – Biomarker TKa”.
You can also see the Overview from the last conference or read Key Findings.
Biovica will be represented again this year.
Recent events
San Antonio, US, 10-13 December, 2024
San Antonio Breast Cancer Symposium
Seven posters on SABCS24
The latest evidence on biomarkers and their application in breast cancer, read the booklet:
“SABCS24 ABSTRACTS – Biomarker TKa”.
You can also see the Overview from the conference or read Key Findings.
Chicago, IL, USA, May 31 - June 4, 2024
ASCO Annual Meeting 2024
“The Art and Science of Cancer Care: From Comfort to Cure.” – ASCO Annual Meeting 2024
San Diego, California, USA, 5-10 April 2024
AACR Annual Meeting 2024
San Antonio, Texas, USA, 5-9 December 2023
SABCS
Amy Williams, Head of Clinical Development and Medical Affairs, Biovica at the San Antonio Breast Cancer Symposium (SABCS) 2023 – sabcs.org.
Lisbon, Portugal, 9-11 November 2023
ABC 7
Biovica COO Hanna Ritzén presenting our poster at Advanced Breast Cancer Seventh International Consensus Conference – abc-lisbon.org
Uppsala, Sweden, 26-27 October 2023
SOTA Breast Cancer Conference
Helle Fisker, VP Commercial, and Caroline Korsbæk Nørby, Marketing Assistant, at the Biovica booth with poster: ‘Next-level cancer monitoring with: First and only FDA-cleared blood test for TKa in HR+ Stage IV BC’.
Chicago, IL, USA, 2-6 June 2023
ASCO Annual Meeting
A poster with DiviTum® TKa results from the SWOG study S0226 was presented on Sunday, June 4.
conferences.asco.org
Berlin, Germany, 11-13 May 2023
ESMO Breast Cancer
Grazia Arpino, MD, PhD, Professor, at University of Naples Federico II, with Biovica’s Helle Fisker, VP, in front of poster “Correlation of circulating tumor DNA (ctDNA) or Thymidine Kinase activity (TKa) Dynamic Patterns with tumor response…in BioItaLEE trial!”
ESMO Breast Cancer
Orlando, Florida, USA, 14-19 April 2023
AACR Annual Meeting
Mattias Bergqvist, Clinical Development Director, and Hanna Ritzén, VP of R&D, at Biovica’s poster in Orlando.
aacr.org
Kalmar, Sweden, 21-23 March 2023
Swedish Oncology Days
The Biovica booth at Onkologidagarna 2023 with poster: Next-level cancer monitoring with: First and only FDA-cleared blood test for TKa in HR+ Stage IV BC.
onkologidagarna.se